Ironwood Pharmaceuticals (NASDAQ:IRWD) will report earnings before markets open on Tuesday, July 23rd. Ironwood Pharmaceuticals, Inc. is a pharmaceutical company. The Company discovers, develops, manufactures, and commercializes marketed drugs. Ironwood products used in treatments of cholesterol, gastrointestinal and cardiovascular diseases, pain, inflammation, and others.
Here is your Cheat Sheet to Ironwood Pharmaceuticals Earnings:
Earnings Expectations: Analysts expect earnings of $-0.68 per share on revenues of $6.48 million.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.55 to a loss $0.65. For the current year, the average estimate is a loss of $2.78, which is worse than the estimate ninety days ago.
Here’s how Ironwood Pharmaceuticals has been performing on an annual basis:
|Revenue ($) in millions||22||36||44||66||150|
|Diluted EPS ($)||NA||NA||-0.59||-0.65||-0.68|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012||Mar. 31, 2013|
|Revenue ($) in millions||14.60||96.41||26.98||3.26|
|Diluted EPS ($)||-0.38||0.42||-0.41||-0.87|
Ironwood Pharmaceuticals has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)